Sortino ratio is not yet available for MRSN. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar stocks
The table compares Mersana Therapeutics, Inc.'s Sortino Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how MRSN's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 4, 2026.
| Symbol | Name | 1Y Sortino Ratio | 5Y Sortino Ratio | 10Y Sortino Ratio | All Time Sortino Ratio |
|---|---|---|---|---|---|
| ENZN | Enzon Pharmaceuticals, Inc. | 153.35 | |||
| ABVX | Abivax SA American Depositary Shares | 12.16 | |||
| INKT | MiNK Therapeutics, Inc. | 8.69 | |||
| COGT | Cogent Biosciences, Inc. | 7.68 | |||
| NKGN | NKGen Biotech Inc. Common Stock | 7.17 | |||
| ZIVOW | Zivo Bioscience Inc. Warrants | 6.84 | |||
| PROK | ProKidney Corp. | 6.79 | |||
| PRAX | Praxis Precision Medicines, Inc. | 6.64 | |||
| RVMDW | Revolution Medicines Inc. Warrant | 6.03 | |||
| RLMD | Relmada Therapeutics, Inc. | 5.61 | |||
| MRSN | Mersana Therapeutics, Inc. | — |
Historical Sortino Ratio
The chart shows MRSN's rolling Sortino ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to downside risk, while declining trends may signal deteriorating risk-adjusted performance or increased volatility during market stress. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.
Identify market cycles by observing when MRSN consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.
Loading charts...
IHow does MRSN fit in your portfolio?
Add your other holdings to see your portfolio's Sortino Ratio and find out.
Analyze Your Portfolio